We are live on
!
Find out more
DSCM
Del-Sette Capital Management Portfolio holdings
AUM
$167M
1-Year Est. Return
38.06%
This Fund
S&P 500
This Quarter
Est. Return
+2.5%
1 Year Est. Return
+38.06%
3 Year Est. Return
+95.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$162M
AUM Growth
+$1.19M
(+0.74%)
Cap. Flow
-$752K
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
51.9%
Holding
61
New
7
Increased
20
Reduced
15
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Morningstar Dividend Leaders Index Fund
FDL
|
+$3.78M |
| 2 |
APA Corp
APA
|
+$3.31M |
| 3 |
AES
AES
|
+$2.98M |
| 4 |
CorMedix
CRMD
|
+$2.33M |
| 5 |
Intuitive Surgical
ISRG
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRISPR Therapeutics
CRSP
|
+$4.05M |
| 2 |
Snowflake
SNOW
|
+$3.17M |
| 3 |
AT&T
T
|
+$3.14M |
| 4 |
Philip Morris
PM
|
+$2.95M |
| 5 |
Alibaba
BABA
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.11% |
| 2 | Communication Services | 6.03% |
| 3 | Healthcare | 5.52% |
| 4 | Consumer Discretionary | 5.05% |
| 5 | Energy | 2.3% |
Similar funds
ASG
JAM
RFA
IAIM
LAM
MG
GSP
TC
Del-Sette Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Del-Sette Capital Management held 61 positions worth $162M, up 0.74% from $161M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Del-Sette Capital Management's Q4 2025 filing shows 7 new, 20 increased, 15 reduced and 7 closed positions. Its largest new stake was APA Corp: 136,738 shares worth $3.34M. The largest sale was CRISPR Therapeutics, an estimated $4.05M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 8.6% a quarter earlier, followed by Communication Services and Healthcare.
- Del-Sette Capital Management's largest Q4 2025 buy was APA Corp: 136,738 shares worth $3.34M.
- Del-Sette Capital Management added most to First Trust Morningstar Dividend Leaders Index Fund in Q4 2025, an estimated $3.78M increase.
- Del-Sette Capital Management's biggest Q4 2025 reduction was Snowflake, cutting an estimated $3.17M.
- Del-Sette Capital Management fully exited CRISPR Therapeutics in Q4 2025, selling an estimated $4.05M.
- Del-Sette Capital Management's ten largest holdings make up 52% of its $162M portfolio in Q4 2025.
- Del-Sette Capital Management opened 7 new positions and closed 7 in Q4 2025.
- Del-Sette Capital Management's portfolio value rose 0.74% quarter-over-quarter to $162M.
Based on Del-Sette Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.